Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Restructuring Costs (2021 - 2026)

Scienture Holdings' (SCNX) quarterly Restructuring Costs came in at $117815.0 in Q2 2026, down 69.13% year-over-year from $381683.0 in Q2 2025, and down 63.88% quarter-over-quarter from $326178.0 in Q1 2026.

Analysis

Scienture Holdings (SCNX) Restructuring Costs (2021 - 2026) Analysis & Trends

Scienture Holdings has disclosed Restructuring Costs across 6 years of filings, most recently posting $117815.0 for Q2 2026.

  • In Q2 2026, Restructuring Costs fell 69.13% year-over-year to $117815.0; the TTM figure through Jun 2026 stood at $1.3 million (down 4.9% YoY), while the FY2025 annual figure was $2.1 million, up 14.57% from the prior year.
  • Restructuring Costs came in at $117815.0 for Q2 2026 at Scienture Holdings, down from $326178.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $724386.0 in Q4 2023 to a low of $117815.0 in Q2 2026.
  • Average Restructuring Costs over 5 years is $295997.8, with a median of $255742.5 recorded in 2022.
  • Year-over-year, Restructuring Costs surged 175.15% in 2023 and tumbled 69.13% in 2026.
  • Over 5 years, Restructuring Costs stood at $263269.0 in 2022, then surged by 175.15% to $724386.0 in 2023, then plunged by 76.3% to $171708.0 in 2024, then soared by 122.29% to $381683.0 in 2025, then slumped by 69.13% to $117815.0 in 2026.
  • Per Business Quant data, the three most recent Restructuring Costs figures were $117815.0 in Q2 2026, $326178.0 in Q1 2026, and $381683.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117,815.00
Mar 31, 2026 326,178.00
Jun 30, 2025 381,683.00
Mar 31, 2025 470,825.00
Jun 30, 2024 171,708.00
Mar 31, 2024 339,047.00
Dec 31, 2023 724,386.00
Sep 30, 2023 408,957.00
Jun 30, 2023 124,799.00
Mar 31, 2023 248,216.00
Dec 31, 2022 263,269.00
Sep 30, 2022 191,007.00
Jun 30, 2022 139,858.00
Mar 31, 2022 236,221.00
Dec 31, 2021 235,199.00
Sep 30, 2021 98,867.00
Jun 30, 2021 203,712.00
Mar 31, 2021 160,047.00